{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:59:01Z","timestamp":1778626741796,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.amjoto.2005.07.018","type":"journal-article","created":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T07:28:35Z","timestamp":1140593315000},"page":"101-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"27","author":[{"given":"Ling-Feng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee-Yin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Rei","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Feng","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka-Wo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuen-Yao","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjoto.2005.07.018_bib1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.amjoto.2005.07.018_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bjc.6600716","article-title":"Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates","volume":"88","author":"Lin","year":"2003","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.amjoto.2005.07.018_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2003.06.158","article-title":"Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival","volume":"21","author":"Lin","year":"2003","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.amjoto.2005.07.018_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<582::AID-CNCR29>3.0.CO;2-R","article-title":"The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma","volume":"83","author":"Marks","year":"1998","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.amjoto.2005.07.018_bib5","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2","article-title":"The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer","volume":"71","author":"Mayer","year":"1993","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.amjoto.2005.07.018_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/bjc.1995.72","article-title":"Proliferating cell nuclear antigen (PCNA) immunostaining\u2014a prognostic factor in ovarian cancer?","volume":"71","author":"Thomas","year":"1995","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.amjoto.2005.07.018_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/jcp.44.8.655","article-title":"Prognostic value of proliferating cell nuclear antigen in gastric carcinoma","volume":"44","author":"Jain","year":"1991","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.amjoto.2005.07.018_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/bjc.1992.237","article-title":"Cell proliferation of transitional cell bladder tumours determined by PCNA\/cyclin immunostaining and its prognostic value","volume":"66","author":"Lipponen","year":"1992","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.amjoto.2005.07.018_bib9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/1097-0142(19920915)70:6<1545::AID-CNCR2820700617>3.0.CO;2-S","article-title":"Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone","volume":"70","author":"Oka","year":"1992","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.amjoto.2005.07.018_bib10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/1097-0142(19951115)76:10<1809::AID-CNCR2820761020>3.0.CO;2-I","article-title":"Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis","volume":"76","author":"Heegaard","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.amjoto.2005.07.018_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0964-1955(96)00029-2","article-title":"Assessment of proliferating cell nuclear antigen in nasopharyngeal carcinoma tissue and its relation to clinical findings","volume":"3","author":"Chan","year":"1997","journal-title":"Oral Oncol"},{"issue":"6","key":"10.1016\/j.amjoto.2005.07.018_bib12","first-page":"868","article-title":"Prognostic value of p53, proliferating cell nuclear antigen, and Ki-67 expression in undifferentiated nasopharyngeal carcinomas","volume":"122","author":"Gen\u00e7","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4B","key":"10.1016\/j.amjoto.2005.07.018_bib13","first-page":"2849","article-title":"Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas","volume":"18","author":"Tsai","year":"1998","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.amjoto.2005.07.018_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","article-title":"p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents","volume":"74","author":"Lowe","year":"1993","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.amjoto.2005.07.018_bib15","first-page":"1591","article-title":"Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up","volume":"2","author":"Caffo","year":"1996","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.amjoto.2005.07.018_bib16","first-page":"1195","article-title":"The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non\u2013small cell lung cancer","volume":"3","author":"Kawasaki","year":"1997","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.amjoto.2005.07.018_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1097-0347(200102)23:2<147::AID-HED1010>3.0.CO;2-#","article-title":"Potential molecular prognostic markers in head and neck squamous cell carcinomas","volume":"23","author":"Quon","year":"2001","journal-title":"Head Neck"},{"issue":"12","key":"10.1016\/j.amjoto.2005.07.018_bib18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/85.12.971","article-title":"Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker","volume":"85","author":"Shin","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"4A","key":"10.1016\/j.amjoto.2005.07.018_bib19","first-page":"2615","article-title":"p21\/WAF 1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression","volume":"17","author":"Kouvidou","year":"1997","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.amjoto.2005.07.018_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3835(00)00582-6","article-title":"Co-expression of p53 and bcl-2 may correlate to the presence of Epstein-Barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma","volume":"160","author":"Niemhom","year":"2000","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.amjoto.2005.07.018_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/bjc.1994.287","article-title":"Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo","volume":"70","author":"Hall","year":"1994","journal-title":"Br J Cancer"},{"issue":"23 Pt. 1","key":"10.1016\/j.amjoto.2005.07.018_bib22","first-page":"6304","article-title":"Participation of p53 protein in the cellular response to DNA damage","volume":"51","author":"Kastan","year":"1991","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.amjoto.2005.07.018_bib23","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1073\/pnas.90.12.5742","article-title":"p53 Mutations increase resistance to ionizing radiation","volume":"90","author":"Lee","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.amjoto.2005.07.018_bib24","first-page":"884","article-title":"Cell proliferation as an independent predictor of survival for patients with advanced nasopharyngeal carcinoma","volume":"10","author":"Faccioli","year":"1997","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.amjoto.2005.07.018_bib25","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/cncr.0679","article-title":"Molecular pathology parameters in human nasopharyngeal carcinoma","volume":"94","author":"Shi","year":"2002","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.amjoto.2005.07.018_bib26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/hed.10307","article-title":"Prognostic significance of tumor angiogenesis, Ki-67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma\u2014a prospective study","volume":"25","author":"Ma","year":"2003","journal-title":"Head Neck"},{"issue":"7","key":"10.1016\/j.amjoto.2005.07.018_bib27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-0347(199810)20:7<640::AID-HED11>3.0.CO;2-K","article-title":"Expression of bcl-2-, p53, and Ki-67 and outcome of patients with primary nasopharyngeal carcinomas following DNA-damaging treatment","volume":"20","author":"Masuda","year":"1998","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.amjoto.2005.07.018_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0046-8177(95)90137-X","article-title":"Assessment of p53 expression in nasopharyngeal carcinoma","volume":"26","author":"Sheu","year":"1995","journal-title":"Hum Pathol"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019607090500147X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019607090500147X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:52:47Z","timestamp":1759294367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019607090500147X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S019607090500147X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2005.07.018","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2005.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}